Showing results (61-70 of 212) with videos related to

Sort By:
Pageof 22
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 21, 2009
Bloodless cancer treatment results of patients who do not want blood transfusion: single center experience of 77 casesSung Yong Oh, Sung-Hyun Kim, Hyuk-Chan Kwon, et al.
Cancer Medicine|March 12, 2022
Relapse in patients with limited-stage ocular adnexal lymphoma treated by chemoimmunotherapy: Extended follow-up of a phase 2 studySung-Yong Kim, Won-Sik Lee, Sung Yong Oh, et al.
Oncology|July 18, 2013
Association between phosphorylated AMP-activated protein kinase and MAPK3/1 expression and prognosis for patients with gastric cancerJong Gwang Kim, Soo Jung Lee, Yee Soo Chae, et al.
Asia-Pacific Journal of Clinical Oncology|April 1, 2016
Intrinsic resistance to sunitinib in patients with metastatic renal cell carcinomaSung Hee Lim, In Gyu Hwang, Jun Ho Ji, et al.
Investigational New Drugs|March 19, 2010
Phase II study of irinotecan/S-1 combination chemotherapy for patients with oxaliplatin-refractory colorectal cancerSung Yong Oh, Young-Tae Ju, Sang-Kyung Choi, et al.
Cancer Research and Treatment|February 13, 2014
Chemotherapy in advanced gastric cancer patients associated with disseminated intravascular coagulationIn Gyu Hwang, Jin Hwa Choi, Se Hoon Park, et al.
Investigational New Drugs|February 4, 2012
A phase II trial of Erlotinib in combination with gemcitabine and cisplatin in advanced pancreatic cancerIn Gyu Hwang, Joung-Soon Jang, Sung Yong Oh, et al.
Cancer Research and Treatment|July 2, 2015
Clinical Significance of Peroxisome Proliferator-Activated Receptor γ and TRAP220 in Patients with Operable Colorectal CancerKyung A Kwon, Jeanho Yun, Sung Yong Oh, et al.
American Journal of Clinical Oncology|April 14, 2009
Second-line treatment with a combination of continuous 5-fluorouracil, doxorubicin, and mitomycin-C (conti-FAM) in gemcitabine-pretreated pancreatic and biliary tract cancerSuee Lee, Sung Yong Oh, Byung Geun Kim, et al.
Cancer Research and Treatment|August 19, 2009
Phase II study of gemcitabine plus cisplatin in patients with anthracycline- and taxane- pretreated metastatic breast cancerJung Hwan Kim, Sung Yong Oh, Hyuk-Chan Kwon, et al.
Pageof 22